Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowBone Marrow CellsWhole-Body IrradiationTransplantation, AutologousLeukemiaAnemia, AplasticTransplantation ConditioningTransplantation ChimeraBusulfanTissue DonorsHematopoietic Stem Cell TransplantationGraft SurvivalLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone and BonesHistocompatibility TestingHistocompatibilityRecurrenceLeukocyte TransfusionCyclophosphamideRadiation ChimeraBone Marrow PurgingGraft vs Tumor EffectLeukemia, Myeloid, AcuteTransplantation, IsogeneicLiver TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionHematologic NeoplasmsGraft vs Host ReactionHematopoietic Stem CellsLymphocyte DepletionCombined Modality TherapyMice, Inbred C57BLHepatic Veno-Occlusive DiseaseImmunosuppressive AgentsAcute DiseaseGraft vs Leukemia EffectLeukemia, MyeloidHematopoiesisLymphocyte TransfusionTime FactorsTreatment OutcomeImmunosuppressionChimeraT-LymphocytesGraft RejectionTransplantation ImmunologyMyelodysplastic SyndromesBone Marrow DiseasesSurvival AnalysisNuclear FamilyCyclosporineKidney TransplantationActuarial AnalysisRetrospective StudiesHLA AntigensLymphoma, Non-HodgkinHematologic DiseasesSevere Combined ImmunodeficiencyMice, Inbred BALB CCytomegalovirus InfectionsBone Marrow ExaminationAntineoplastic Combined Chemotherapy ProtocolsSurvival RateFatal OutcomeFollow-Up StudiesCytarabineStem Cell TransplantationBone RemodelingDisease-Free SurvivalBone Marrow NeoplasmsPancytopeniaLeukocyte CountSpleenColony-Forming Units AssayHeart TransplantationGranulocyte Colony-Stimulating FactorFlow CytometryEtoposideLymphomaPrognosisInfectionMultiple MyelomaMethotrexateCell DifferentiationLung TransplantationLeukemia, Myelomonocytic, AcuteAntilymphocyte SerumAnemia, Refractory, with Excess of BlastsNeoplasm, ResidualAntibodies, MonoclonalBone DensityImmunophenotypingCyclosporinsCells, CulturedImmunocompromised HostThymus Gland